The goal of this observational study is to enroll all patients evaluated at the specialized Cardiogenetic Center within the Cardiology Department of the University of Ferrara, Italy. The primary aim of the registry is to collect comprehensive clinical, genetic, and electrophysiological data from individuals with suspected or confirmed arrhythmogenic conditions. By systematically documenting patient demographics, family history, clinical presentations, diagnostic findings, and treatment outcomes, the registry seeks to enhance our understanding of the genetic basis and clinical implications of genetically driven arrhythmias and systemic syndromes. This registry will facilitate long-term follow-up of enrolled patients to assess the natural history of arrhythmogenic disorders and the effectiveness of various therapeutic interventions. Additionally, it aims to identify potential risk factors associated with adverse outcomes, such as sudden cardiac death or major arrhythmic events.
Patients evaluated at the Cardiogenetic Center of the University of Ferrara in Ferrara, Italy.
Having a proven cardiogenetic disease
Refuse to provide informed consents
Patients not having a cardiogenic disease
Study Population
Cohort
Prospective
Not listed
All-cause of death
The investigators will monitor patient's all causes death
Cardiovascular-related death
The investigators will monitor patient's all causes death
Onset or worsening heart faillure
The investigators will assess patient's hemodynamic stability over the years, monitoring the onset or the worsening of heart failure
Onset/worsening of atrial tachyarrhythmias
Onset/worsening of ventricular tachyarrhythmias
The investigators will monitor patient's rhythm over the years, assessing the onset or the worsening of ventricular tachyarrhythmias.
Need for PM/ICD
The investigators will evaluate procedural time of different cardiac pacing modalities
Click on the lead sponsor to view all of their trials.
